Coronary disease & ACSCohort study

Socioeconomic differences in patient pathways of secondary prevention after ischaemic heart disease: a nationwide cohort study

Eur J Prev CardiolPublished

  • Retrospective cohort study
  • nationwide
  • population-based

Authors' conclusion

Substantial socioeconomic differences persist in secondary prevention after IHD, reflecting inequalities in access to and engagement with care, despite a universal healthcare system.

Study context

Population
Individuals hospitalised with ischaemic heart disease, 2016–2022
Participants
93,159 individuals
Exposure
Socioeconomic groups
Outcome
Comprehensive secondary prevention: all three components (CR, preventive medication, annual GP follow-up)

Main finding

As reported in the abstract

Receiving all three components
adjusted, modified Poisson regression
Relative risk (95% CI)
Short education
0.91(0.88–0.94)
Living alone
0.77(0.75–0.79)
Low income
0.70(0.67–0.73)
Unemployment
0.82(0.75–0.89)
Achieved all three components (whole cohort)
25.9%

Observational data: associations, not effects.

Further findings

Cardiac rehabilitation (CR) initiation and adherence · within six months

Initiated CR
41.2%
Adhered, of those initiating
73.7%
Socioeconomic differences most pronounced for CR uptake

Preventive medication and general practice (GP) follow-up

Redeemed antiplatelet
86.1%
Redeemed statin
77.0%
Annual GP follow-up
56.0%

None of the recommended components

Received none
7.6%

Original publication

Socioeconomic differences in patient pathways of secondary prevention after ischaemic heart disease: a nationwide cohort study. Eur J Prev Cardiol. Published 6 June 2026. doi:10.1093/eurjpc/zwag309

Summarised from the published abstract; every number is checked against it